Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.83 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.83 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.83 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.75 |
| ▸ | MAPT | P10636 | 6/20 | 0.75 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.75 |
| ▸ | MEN1 | O00255 | 4/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.75 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.75 |
| ▸ | POLB | P06746 | 3/20 | 0.75 |
| ▸ | IP6K2 | Q9UHH9 | 3/20 | 0.71 |
| ▸ | XDH | P47989 | 2/20 | 0.71 |
| ▸ | IPMK | Q8NFU5 | 2/20 | 0.71 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.71 |
| ▸ | KDM1A | O60341 | 1/20 | 0.71 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29574485 | 0.95 | MAOA (0.79) | MAOAAKR1B1MAPK8CYP1B1MAPT | |
| SCHEMBL6095495 | 0.93 | MAOA (0.76) | MAOAAKR1B1MAPK8CYP1B1MAPT | |
| Corymbosin SCHEMBL29426420 | 0.92 | ABCB1 (0.78) | MAOAAKR1B1MAPK8CYP1B1MAPT | |
| Corymbosin SCHEMBL1976826 | 0.92 | ABCB1 (0.78) | MAOAAKR1B1MAPK8CYP1B1MAPT | |
| SCHEMBL16894650 | 0.91 | ABCB1 (0.76) | MAOAAKR1B1MAPK8CYP1B1MAPT | |
| Tricin SCHEMBL44475 | 0.91 | MAOA (1.00) | MAOAAKR1B1MAPK8CYP1B1MAPT | |
| Tricin SCHEMBL29712335 | 0.91 | MAOA (1.00) | MAOAAKR1B1MAPK8CYP1B1MAPT | |
| Tricin SCHEMBL10809395 | 0.90 | MAOA (0.97) | MAOAAKR1B1MAPK8CYP1B1MAPT | |
| SCHEMBL12378833 | 0.90 | MAOA (0.92) | MAOAAKR1B1MAPK8CYP1B1MAPT | |
| SCHEMBL29576775 | 0.90 | MAOA (0.92) | MAOAAKR1B1MAPK8CYP1B1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118091005-A | Method for detecting multiple components in deer astragalus kidney-tonifying particles | 上海市第七人民医院(上海中医药大学附属第七人民医院) | 2024-05-28 | — | — | CN | claimed |
| CN-114272335-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of children | 华子昂 | 2022-04-05 | — | — | CN | claimed |
| EP-1067913-B1 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | BIORESPONSE LLC (US) | 2012-08-29 | — | — | EP | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| US-20250263774-A1 | DISCOVERING NEW XENOBIOTIC SUBSTRATES OF AN UDP-GLYCOSYLTRANSFERASE WITH A HIGH-THROUGHPUT METHOD | UNIV NORTH TEXAS (US) | 2025-08-21 | — | — | US | disclosed |
| CN-119592609-A | Gene for regulating and controlling wheat multi-stress resistance and application thereof | 华中农业大学 | 2025-03-11 | — | — | CN | disclosed |
| CN-117740961-A | Compound analysis method of liquorice and liquorice probiotics fermentation preparation | 北京中医药大学 | 2024-03-22 | — | — | CN | disclosed |
| CN-114272335-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of children | 华子昂 | 2022-04-05 | — | — | CN | disclosed |
| EP-2730431-B1 | Rubber composition and tire with rubber containing flavone | GOODYEAR TIRE & RUBBER (US) | 2017-06-28 | — | — | EP | disclosed |
| CN-105194389-A | Preparation for treating bone tuberculosis and preparation method thereof | ZHANG SHIHAI | 2015-12-30 | — | — | CN | disclosed |
| US-20140135433-A1 | TIRE WITH RUBBER CONTAINING FLAVONE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2014-05-15 | — | — | US | disclosed |
| EP-2730431-A1 | Rubber composition and tire with rubber containing flavone | The Goodyear Tire & Rubber Company (US) | 2014-05-14 | — | — | EP | disclosed |
| US-20080287374-A1 | BREAST CANCER-RESISTANT PROTEIN INHIBITOR | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 2008-11-20 | — | — | US | disclosed |
| US-20070254859-A1 | Compounds exhibiting efflux inhibitor activity and composition and uses thereof | EASTMAN CHEMICAL COMPANY | 2007-11-01 | — | — | US | disclosed |
| US-20060135445-A1 | Breast cancer-resistant protein inhibitor | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 2006-06-22 | — | — | US | disclosed |
| EP-1591112-A1 | BREAST CANCER-RESISTANT PROTEIN INHIBITOR | Kabushiki Kaisha Yakult Honsha (JP) | 2005-11-02 | — | — | EP | disclosed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | disclosed |
| WO-2003057210-A1 | COMPOSITIONS AND METHODS FOR INCREASING CELL PROLIFERATION COMPRISING A FLAVONOID | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2003-07-17 | — | — | WO | disclosed |
| US-20030125264-A1 | Methods For Treating Wounds | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-07-03 | — | — | US | disclosed |
| US-6086915-A | HEATING THE SOLUBILIZING EMULSIFIER, ADDING SOLVENT AND ONE OR MORE PHOSPHOLIPID SURFACTANTS, DISSOLVING IN THIS SOLUTION ONE OR MORE HYDROPHOBIC PHYTOCHEMICALS, ADDING ENCAPSULATORS, FORMING MICROEMULSION, SPRAY DRYING THE SOLUTION | BIORESPONSE L.L.C. (US) | 2000-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070254859-A1 | Compounds exhibiting efflux inhibitor activity and composition and uses thereof | ABCC4, NCOA4, NR4A3 | MAOA 1628/4885AKR1B1 384/4885MAPK8 2161/4885 |
| US-20060135445-A1 | Breast cancer-resistant protein inhibitor | ABCC1, BCR, BRCA1 | MAOA 3721/4885AKR1B1 797/4885MAPK8 1001/4885 |
| US-20080287374-A1 | BREAST CANCER-RESISTANT PROTEIN INHIBITOR | ABCC1, BCR, BRCA1 | MAOA 3721/4885AKR1B1 797/4885MAPK8 1001/4885 |
| US-20030125264-A1 | Methods For Treating Wounds | FGF2, MMP1, FIBP | MAOA 678/4885AKR1B1 1262/4885MAPK8 645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.